Among the most successful systems for homogeneous catalysis, hydrogenation catalysts capable of activating molecular hydrogen, take outstanding roles in research laboratories and in industry. To open up the field of continuous catalytic hydrogenations a novel membrane reactor concept was developed and successfully applied for hydrogenations with dihydrogen both for chemical and for enzymatic catalysis. The hydrogenase I of the archaeon Pyrococcus furiosus was utilized for the continuous hydrogenation of NADP to NADPH with recycling of the enzyme by means of ultrafiltration. The well known PyrPhos-Rh system was used for the enantioselective synthesis of an amino acid derivative by hydrogenation.Keywords: asymmetric catalysis; catalyst immobilization; cofactors; enzyme catalysis; homogeneous catalysis; hydrogenation; membranes; reduction Here we report our most recent efforts to extend the range of feasible reactions in the membrane reactor [1] to hydrogenation with dihydrogen as reducing agent. The direct usage of hydrogen has several advantages over the usage of hydrogen transfer agents like 2-propanol [2] since it constitutes a cheaper and more powerful means of reduction that can be used in large excess and be easily removed, thus not hampering downstream processing.For this approach a novel reactor concept was developed for the continuous dosage of gaseous reactants via a dense polymer membrane. The feasibility of the application of volume-aeration to hydrogenation was investigated for chemical and enzymatic catalysis. We chose the homogeneous hydrogenation catalyst PyrPhos [3] as the chemical representative, whereas the hydrogenase I from the hyperthermophilic archeon Pyrococcus furiosus (PfH) illustrates the enzymatic approach.[4] Both catalysts activate hydrogen; the PyrPhos system for the enantioselective reduction of activated double bonds, whereas the PfH is capable of heterolytic cleavage of hydrogen and regioselective 1,4-hydride addition to the oxidized form of the phosphorylated nicotinamide cofactor: NADP (Scheme 1). In the case of the enzymatic approach the macromolecular catalyst was recycled by means of ultrafiltration.Reactor Set-Up: For continuous dosage of dihydrogen in a continuously operated membrane reactor a new setup was developed. The general scheme is shown in Figure 1. The delivery of gaseous reactants can be achieved by pressure-enhanced diffusion through dense polymer membranes, which has been shown in fluidized bed for animal cell culture.[5] We chose polytetrafluoroScheme 1. Hydrogenation of a) 2-N-acetylamidocinnamic acid (AAZ) with PyrPhos and b) NADP with the hydrogenase from Pyrococcus furiosus (PfH) (for NADP and NADPH only the reduced nicotinamide moiety is shown).